Summary
Quest Diagnostics, a leader in diagnostic testing, reported $7.4 billion in net revenues for the fiscal year ended December 31, 2010. The company's strategy focuses on leveraging its extensive assets, driving medical innovation, delivering a superior patient experience, and maintaining high quality through Six Sigma processes. Significant investments in healthcare information technology, such as the Care360 suite, are aimed at improving patient care and clinician workflow, with the Care360 EHR solution receiving ONC-ATCB certification. The company operates in a competitive market influenced by healthcare reform, demographic trends, and technological advancements. Quest Diagnostics' diverse revenue streams include clinical testing (91% of 2010 revenues), life insurer services, clinical trials testing, diagnostic products, and employer services. Despite a slight decrease in net revenues compared to 2009, the company managed its costs effectively, resulting in stable operating income as a percentage of revenue, supported by reduced bad debt expenses and operational efficiencies.
Financial Highlights
57 data points| Revenue | $7.26B |
| Cost of Revenue | $4.28B |
| Gross Profit | $3.05B |
| SG&A Expenses | $1.66B |
| Operating Expenses | $5.98B |
| Operating Income | $1.28B |
| Interest Expense | $147.50M |
| Net Income | $720.89M |
| EPS (Basic) | $4.08 |
| EPS (Diluted) | $4.05 |
| Shares Outstanding (Basic) | 175.68M |
| Shares Outstanding (Diluted) | 177.32M |
Key Highlights
- 1Quest Diagnostics generated $7.4 billion in net revenues for the fiscal year ended December 31, 2010.
- 2The company's strategy emphasizes leveraging its broad assets, medical innovation, superior patient experience, and Six Sigma quality.
- 3Clinical testing accounted for the vast majority of revenue (91%), with other segments including life insurer services, clinical trials, and diagnostics products.
- 4Investments in healthcare IT, notably the Care360 suite, are highlighted as a differentiator, supporting electronic health records and physician workflow.
- 5The company experienced a slight revenue decline of 1.2% compared to the prior year, primarily due to lower clinical testing volumes.
- 6Operating income remained strong as a percentage of revenue, supported by cost management initiatives, including reduced bad debt expenses.
- 7Quest Diagnostics continues to operate in a dynamic healthcare landscape influenced by regulatory changes, competition, and technological advancements.